Filing Flows

Filing Flows › Freshpet (FRPT) › Guidance & outlook

Freshpet (FRPT) guidance and outlook

Freshpet (FRPT) raised some and lowered other parts of its guidance on Nov 4, 2026: Revenue +12% to +13% for FY2026; EBITDA $215M–$220M for FY2026; Capital expenditures $125M–$150M for FY2026; Gross margin 49% for FY2027. Freshpet's 10-Q filed Nov 4, 2026 makes 18 forward-looking statements.

Guidance and outlook

Freshpet: what its forward-looking statements are about (10-Q filed 2026-11-04)Freshpet: what its forward-looking statements are about (10-Q filed 2026-11-04)Other5Costs3Demand3Capital spending2Backlog1The economy1Margins1Supply chain1Financing1
18 statements; tone +0.28 (−1 all cautious, +1 all confident); 4 hedged.
Freshpet: outlook statements against the filing beforeFreshpet: outlook statements against the filing beforeConfident5

Latest guidance

MetricPeriodRangeChange
RevenueFY2026+12% to +13%raised
EBITDAFY2026$215M–$220Mraised
Capital expendituresFY2026$125M–$150Mlowered
Gross marginFY202749%reaffirmed
EBITDA marginFY202720%–22%reaffirmed

From the earnings release filed Nov 4, 2026 (8-K on EDGAR).

Forward-looking statements, 10-Q filed Nov 4, 2026

Freshpet's latest quarter

Freshpet, Q3 2026: revenue $318M (+10% year over year), operating margin 11.1%, net earnings $29.7M, operating cash flow $60.8M. The chart follows the revenue to costs, profit and cash.

Questions

Did Freshpet raise or lower its guidance?

Freshpet (FRPT) raised some and lowered other parts of its guidance on Nov 4, 2026: Revenue +12% to +13% for FY2026; EBITDA $215M–$220M for FY2026; Capital expenditures $125M–$150M for FY2026; Gross margin 49% for FY2027.

What does Freshpet expect?

We expect to continue to mitigate any adverse movement in input costs through a combination of cost management and price increases. The Company recognizes share-based compensation based on the value of the portion of share-based payment awards that is ultimately expected to vest during the period. Our presentation of the non-GAAP financial measures should not be construed as an inference that our future results will be unaffected by the expenses that are excluded from that term or by unusual or non-recurring items.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.